active surveillance
Prostate Cancer Active Surveillance's Hidden Cost in 2025
Active surveillance for low-risk prostate cancer in 2025 saves patients from surgery and radiation while preserving health for at least ten years, but it carries hidden economic costs that health systems must address. By postponing invasive procedures, the strategy delays upfront spending, yet the ongoing monitoring, imaging, and occasional biopsies